Pharma-Bio Serv EPS
Earnings per Share (EPS) of Pharma-Bio Serv (PBSV) as of Nov 14, 2026.
Get this data via API
Financial Data API
EPS
-0.00USD
YoY
-87.05%
Last updated:
Earnings per Share (EPS) of Pharma-Bio Serv is 2025 -0.00 USD. Earnings per Share (EPS) of Pharma-Bio Serv was 2024 -0.03 USD. It decreases by -87.05% higher compared to the previous year.
The Pharma-Bio Serv EPS history
3 Years
10 Years
25 Years
Max
EPS
Date
EPS
Jan 1, 2020
0.09 USD
Jan 1, 2021
-0.09 USD
Jan 1, 2022
0.04 USD
Jan 1, 2023
0.06 USD
Jan 1, 2024
-0.03 USD
Jan 1, 2025
-0.00 USD
Jan 1, 2026 (e)
0.04 USD
Jan 1, 2027 (e)
0.11 USD
| YEAR | EPS | YoY |
|---|---|---|
| est | 0.11USD | +175.00% |
| est | 0.04USD | -1,012.02% |
| -0.00USD | -87.05% | |
| -0.03USD | -159.37% | |
| 0.06USD | +30.03% | |
| 0.04USD | -148.31% | |
| -0.09USD | -201.86% | |
| 0.09USD | -1.77% | |
| 0.09USD | +63.54% | |
| 0.06USD | -190.57% | |
| -0.06USD | +449.54% | |
| -0.01USD | -115.80% | |
| 0.07USD | -32.64% | |
| 0.10USD | -51.52% | |
| 0.22USD | +5.78% | |
| 0.20USD | +45.85% | |
| 0.14USD | +742.79% | |
| 0.02USD | -30.62% | |
| 0.02USD | -64.16% | |
| 0.07USD | -22.04% | |
| 0.09USD | -34.48% | |
| 0.13USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Pharma-Bio Serv Stock analysis
What does Pharma-Bio Serv do? Pharma-Bio Serv Inc is an international company based in Puerto Rico that was founded in 1993. The company offers a wide range of high-quality services to the pharmaceutical, biotech, and hospital industries and has become a leading service provider in this field. Pharma-Bio Serv is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Pharma-Bio Serv stock
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Pharma-Bio Serv since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Pharma-Bio Serv
All Key Metrics — Pharma-Bio Serv
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth